CIK 0001991792 · Large accelerated filer
CG Oncology, Inc.
Sign in to watch- Ticker
- CGON
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371611499
- Phone
- (949) 409-3700
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $135,045
- in 2 filings, $135K under 10b5-1 plans
Net −$135,045. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-29 | Mulay James Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −12,755 | 0 | ||
| 2025-09-19 | Mulay James Director | Option exercise 10b5-1 | +3,574 | $1.82 | $7K | 3,574 |
| 2025-09-19 | Mulay James Director | Sale 10b5-1 | −3,574 | $38.99 | $139K | 0 |
| 2025-09-19 | Mulay James Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −3,574 | 12,755 | ||
| 2025-09-18 | Mulay James Director | Option exercise 10b5-1 | +19,112 | $1.82 | $35K | 19,112 |
| 2025-09-18 | Mulay James Director | Sale 10b5-1 | −19,112 | $39.01 | $746K | 0 |
| 2025-09-18 | Mulay James Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −19,112 | 16,329 | ||
| 2025-09-15 | POST LEONARD E Director | Option exercise 10b5-1 | +1,000 | $0.60 | $600 | 1,000 |
| 2025-09-15 | POST LEONARD E Director | Sale 10b5-1 | −1,000 | $35.10 | $35K | 0 |
| 2025-09-15 | POST LEONARD E Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −1,000 | 124,077 | ||
| 2025-09-11 | Liu Brian Guan-Chyun Director | Purchase 10b5-1 | +1,515,151 | $33.00 | $50.0M | 1,515,151 |
| 2025-09-05 | Mulay James Director | Option exercise 10b5-1 | +27,015 | $0.60 | $16K | 27,015 |
| 2025-09-05 | Mulay James Director | Sale 10b5-1 | −12,342 | $30.47 | $376K | 14,673 |
| 2025-09-05 | Mulay James Director | Sale 10b5-1 | −4,095 | $31.42 | $129K | 10,578 |
| 2025-09-05 | Mulay James Director | Sale 10b5-1 | −7,465 | $32.64 | $244K | 3,113 |
| 2025-09-05 | Mulay James Director | Sale 10b5-1 | −3,113 | $33.22 | $103K | 0 |
| 2025-09-05 | Mulay James Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −27,015 | 0 | ||
| 2025-09-03 | Song Hong Fang Director | Sale 10b5-1 | −69,695 | $27.60 | $1.9M | 2,934,236 |
| 2025-09-03 | Song Hong Fang Director | Sale 10b5-1 | −30,105 | $28.24 | $850K | 2,904,131 |
| 2025-09-03 | Song Hong Fang Director | Sale 10b5-1 | −100 | $28.96 | $3K | 2,904,031 |
Page 5 of 9 · 172 trades